Example: bankruptcy

処方鑑査における 検査値 ... - ho.chiba-u.ac.jp

1 ST. 3 6% WBC x103/ L * SEG (%) - HGB g/dL PLT x103/ L 150 350 RBC x106/ L M. Male ( ) F. Female ( ) HGB HGB 14 12g/dL WBC HGB PLT WBC HGB PLT WBC HGB PLT WBC HGB PLT (3-10%) (20-50%) (30-70%) (0-5%) (0-2%) Ex.

処方鑑査における 検査値利用に関する勉強会 第3回(血液) 2014.9.18 千葉大学病院 薬剤部 松本 和彦 1

Tags:

  Chiba, Chiba u

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of 処方鑑査における 検査値 ... - ho.chiba-u.ac.jp

1 1 ST. 3 6% WBC x103/ L * SEG (%) - HGB g/dL PLT x103/ L 150 350 RBC x106/ L M. Male ( ) F. Female ( ) HGB HGB 14 12g/dL WBC HGB PLT WBC HGB PLT WBC HGB PLT WBC HGB PLT (3-10%) (20-50%) (30-70%) (0-5%) (0-2%) Ex.

2 Etc. 1 2 WBC(SEG,ST) PLT HGB 2 3 Q&A Q&A42 (Febrile Neutropenia : FN) 1. C C 2. 500/ L 1000/ L 48 500 L Common Terminology Criteria for Adverse Events (CTCAE) Version LLN. ( ) Lower Limit of Normal JCOG ( CTCAE ) CTCAE Grade1 Grade2 Grade3 Grade4 Grade5 - LLN-1500 1500-1000 1000-500 500 - LLN-75 75-50 50-25 25 - ( ) 2014/09/18 36 20mg 4T 2 ( ) 14 eGFR 79. , , Cys-C:**, GOT:20, GPT:13, ALP:175, T- , , , , , PLT:288, , CPK:25L, TSH:**,A1C- eGFR 79.

3 , , Cys-C:**, GOT:20, GPT:13, ALP:175, T- , , , , , PLT:288, , CPK:25L, TSH:**,A1C- ( + )/100 2500 2. WBC, SEG, ST, HGB, PLT 1. WBC, SEG, ST 2. 2 2 1 1. 1. 2. Ex. , , etc. 29 2013 11 S(50) 2014 5 2014 6 (5)3T/ 1 2014 7 3 (5)3T/ 1 90 2014 7 13 C 2014 7 14 G-CSF 3T/ 1 WBC(*103) 02 07 03 07 04 07 05 07 06 07 07 07 08 07 09 07 10 07 11 07 12 07 13 07 14 07 15 07 16 07 17 07 18 07 19 07 20 07 21 07 22 07 23 07 24 07 25 07 26 07 27 07 28 07 29 07 30 07 31 SEGWBCCTCAE Grade1 Grade2 Grade3 Grade4 Grade5 LLN-1500 1500-1000 1000-500 500 - SEG MEPM G-CSF LVFX VCM (WBC,SEG,ST) 2014/09/18 40 5mg 2T ( ) 56 eGFR , , Cys-C:**, GOT.

4 20, GPT:13, ALP:175, T- , , , , , PLT:288, , CPK:25L, TSH:**, A1C- eGFR , , Cys-C:**, GOT:20, GPT:13, ALP:175, T- , , , , , PLT:288, , CPK:25L, TSH:**, A1C- ( + )/100 =2500 (WBC,SEG,ST) 1. 2. 3. 4. 5. 6. PMDA HP PMDA HP PMDA 2. WBC, SEG, ST, HGB, PLT 1. WBC, SEG, ST Q&A WBC ( ) ( ) 7 14 7 10 7 14 7 10 10 14 7 10 10 14 10 14 10 14 10 14 10 14 10 14 10 14 7 10 (DTX) 7 14 5 10 14 21 10 14 WBC Q&A PLT ( ) ( ) 5 10 7 10 7 10 7 10 10 14 7 10 10 14 7 10 14 21 7 21 14 21 7 21 21 28 14 21 14 21 7 21 PLT SEG (WBC,PLT *1000)

5 DTX DTX DTX 2112 5580 5037 190 187 147 189 159 55 TS-1 / DTX WBC,SEG,ST,HGB,PLT eGFR,CRE,Cys-C 2014/09/18 67 OD 20mg 4T 2 ( ) 14 eGFR , , Cys-C:**, GOT:20, GPT:13, ALP:175, T- , , , , , PLT:288, , CPK:25L, 1 1 OH CI OH N N O O NH H N KO2C P-450 5-FU 5-FU 200 5-FU N O O F O NH FT P450 F- -Ala CDHP FUMP FUMP FUMP TS-FdUMP F-RNA Oxo 5-FU 5-FU FT 5-FU CDHP Oxo FT CDHP Oxo=1 1 5-FU CDHP Oxo FT Oxo CDHP 1 1 1.

6 2. 3. 4. 5. 6. 1. 2. 3. 4.


Related search queries